CClinicalTrials.gg
Not yet recruitingNCT06132672Updated Apr 30, 2026

Medical Mistrust Among Hispanic/Latino Gay, Bisexual and Other Men Who Have Sex With Men (HLMSM)

An interventional study of Navigators (peer navigator) training and delayed-intervention in Human Immunodeficiency Virus, sponsored by Wake Forest University Health Sciences. Not yet recruiting at 1 site in United States. Open to male participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-30.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Health services research

Phase
Not applicable
Study type
Interventional
Enrollment
144
Allocation
Randomized
Ages
18 Years and older
Sex
Male
01

Study summary

There is an urgent need to address HIV inequities and disparities in the US, particularly within vulnerable communities such as Hispanic/Latino gay, bisexual, and other men who have sex with men (HLMSM).

Read the detailed description

Medical mistrust is associated with HIV disparities among HLMSM because mistrust may result in delayed or reduced use of needed HIV prevention (e.g., HIV testing and Pre-exposure prophylaxis (PrEP) uptake) and care (e.g., AntiretroViral Therapy [ART]) services.

While advances have been made to increase the use of HIV prevention and care services, profound disparities persist, and a need remains for increased understanding of the multilevel drivers of medical mistrust and for effective interventions to address these drivers among HLMSM in the US.

This research proposes a mixed-method study that includes rigorous qualitative and quantitative methods to better understand the drivers of medical mistrust among Spanish-speaking, English-speaking, and bilingual (including Spanish and English, or an indigenous language and Spanish and/or English) HLMSM. This study also proposes to refine and test a multilevel intervention designed to address medical mistrust and increase the use of needed HIV prevention and care services among diverse HLMSM in Mecklenburg County, NC, a jurisdiction prioritized by the Ending the HIV Epidemic in the US (EHE) initiative.

02

Conditions studied

  • Human Immunodeficiency Virus

Keywords

  • Hispanic/Latino gay
  • bisexual men
  • HIV prevention
03

In context

Acquired Immunodeficiency Syndrome

2,040 studies on the registry are indexed under Acquired Immunodeficiency Syndrome; 272 are open to participants now.

This study's planned enrollment of 144 is above the median of 105 across 1,543 interventional studies indexed under Acquired Immunodeficiency Syndrome.

Browse Acquired Immunodeficiency Syndrome studies →

Lead sponsor

Wake Forest University Health Sciences is the lead sponsor of 1,320 studies on the registry; 199 are open to participants now.

Of its 323 completed or terminated interventional studies of FDA-regulated products, 243 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Male
Accepts healthy volunteers
Yes

Inclusion criteria

  • reside in Mecklenburg County, NC
  • identify as Hispanic/Latino
  • be ≥18 years of age
  • speak English and Spanish
  • report identifying as male and having had sex with at least 1 man in the past 6 months
  • provide informed consent

Exclusion criteria

Exclusion Criteria:

  • less than 18 years of age
  • female
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
144 participants (estimated)

Study arms

  • Experimental
    Navigators (peer navigator) training

    Training is designed to increase knowledge and skills. Navigators in the intervention group will be trained and supported for 12 months of implementation across years 3 and 4

    Behavioral: Navigators (peer navigator) training

  • Experimental
    delayed-intervention group

    Training is designed to increase knowledge and skills. The delayed-intervention group will be trained in year 5

    Behavioral: delayed-intervention

Interventions

  • BehavioralNavigators (peer navigator) training

    The Navigators training will be designed to increase knowledge and skills to help others (i.e., social network members). Navigators in the intervention group will be trained and supported for 12 months of implementation across years 3 and 4

  • Behavioraldelayed-intervention

    Those in the delayed-intervention group will be trained in year 5

06

What researchers measure

Primary outcomes

  1. Change in Rate of medical mistrust

    The Group-Based Medical Mistrust Scale (GBMMS) - The response key was a Likert-type scale ranging from 1 (strongly disagree) to 5 (strongly agree) and the score range was 12 to 60 - higher scores indicate greater levels of medical mistrust

    Time frame: baseline to post-intervention up to 18 months

  2. Change in Rate of Human Immunodeficiency Virus (HIV) testing

    Change in Rate of Human Immunodeficiency Virus (HIV) testing - Self-Report - did participant use testing in past 12 months

    Time frame: baseline to post-intervention up to 18 months

  3. Change in Rate of pre-exposure prophylaxis (PrEP) uptake

    Change in Rate of pre-exposure prophylaxis (PrEP) uptake - did participant use PrEP in past 12 months

    Time frame: baseline to post-intervention up to 18 months

  4. Change in the amount of use of HIV care services

    Change in the amount of use of HIV care services - did participant use HIV care in past 12 months

    Time frame: baseline to post-intervention up to 18 months

07

Study locations

1 site
  • Wake Forest University Health Sciences
    Winston-Salem, North Carolina 27157, United States
08

References and documents

Individual participant data

Plan to share: Yes — Sharing data generated from this study is an essential part of our proposed activities. This study will generate both quantitative and qualitative data

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06132672
Lead sponsor
Wake Forest University Health Sciences
Responsible party
Sponsor
First posted
Nov 15, 2023
Start date
Mar 2027 (estimated)
Primary completion
Aug 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Apr 30, 2026

Study contacts

Lisa L Norfleet
Contact
Lisa.Lynn.Lewis@wakehealth.edu
336.713.5074
Scott D Rhodes, PhD
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion